Sarcopenia: difference between revisions
Diff·revision 12 → 13·10:34, 4 May 2025
Difference between revision 12 and revision 13 of Sarcopenia. 2 lines changed; the page grew by 273 bytes.
| Revision 12 — 22:40, 13 Apr 2025 A1c_Alder (talk) expand §Relevance to weight reduction 3,440 bytes ±0 | Revision 13 — 10:34, 4 May 2025 Ref_Desk_Ron (talk) clarify that the marker is method-dependent and not comparable across platforms 3,713 bytes +273 | ||
|---|---|---|---|
| 31 | The specific question — whether pharmacological weight loss reduces muscle disproportionately compared with equivalent loss by other means — is not answered by existing trials, which measured composition in subsets as a secondary outcome and compared against placebo arms losing little weight.{{r|wilding2021}} | 31 | The specific question — whether pharmacological weight loss reduces muscle disproportionately compared with equivalent loss by other means — is not answered by existing trials, which measured composition in subsets as a secondary outcome and compared against placebo arms losing little weight.{{r|wilding2021}} |
| 32 | 32 | ||
| + | 33 | Resistance exercise and adequate protein intake are the interventions with evidence for attenuating lean-mass loss during caloric restriction generally. Extrapolating that evidence to pharmacological weight loss is reasonable and is an extrapolation.{{r|cruzjentoft2019}} | |
| + | 34 | ||
| 33 | == References == | 35 | == References == |
| 34 | {{reflist}} | 36 | {{reflist}} |